These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

836 related articles for article (PubMed ID: 18336927)

  • 1. Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions.
    Bausch DG; Sprecher AG; Jeffs B; Boumandouki P
    Antiviral Res; 2008 Apr; 78(1):150-61. PubMed ID: 18336927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Marburg and Ebola hemorrhagic fevers--pathogens, epidemiology and therapy].
    Stock I
    Med Monatsschr Pharm; 2014 Sep; 37(9):324-30; quiz 331-2. PubMed ID: 25282746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marburg and Ebola--arming ourselves against the deadly filoviruses.
    Peters CJ
    N Engl J Med; 2005 Jun; 352(25):2571-3. PubMed ID: 15972860
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ebola and Marburg hemorrhagic fever viruses: update on filoviruses].
    Leroy E; Baize S; Gonzalez JP
    Med Trop (Mars); 2011 Apr; 71(2):111-21. PubMed ID: 21695865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of vaccines for Marburg hemorrhagic fever.
    Bausch DG; Geisbert TW
    Expert Rev Vaccines; 2007 Feb; 6(1):57-74. PubMed ID: 17280479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Threat of Marburg and Ebola viral haemorrhagic fevers in Africa.
    Tukei PM
    East Afr Med J; 1996 Jan; 73(1):27-31. PubMed ID: 8625857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of treatment strategies to combat Ebola and Marburg viruses.
    Paragas J; Geisbert TW
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):67-76. PubMed ID: 16441210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug targets in infections with Ebola and Marburg viruses.
    Gene OG; Julia BE; Vanessa MR; Victoria WJ; Thomas GW; Lisa HE
    Infect Disord Drug Targets; 2009 Apr; 9(2):191-200. PubMed ID: 19275706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons learned during active epidemiological surveillance of Ebola and Marburg viral hemorrhagic fever epidemics in Africa.
    Allaranga Y; Kone ML; Formenty P; Libama F; Boumandouki P; Woodfill CJ; Sow I; Duale S; Alemu W; Yada A
    East Afr J Public Health; 2010 Mar; 7(1):30-6. PubMed ID: 21413569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comments on the article "Marburg and Ebola virus infections in laboratory non-human primates: a literature review". Soren Schou and Axel Kornerup Hansen. Comparative Medicine, 2000. 50:108-123.
    Weber H
    Comp Med; 2000 Oct; 50(5):479-80. PubMed ID: 11099125
    [No Abstract]   [Full Text] [Related]  

  • 11. Filoviruses: recent advances and future challenges.
    Bray M; Pilch R
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):917-21. PubMed ID: 17181407
    [No Abstract]   [Full Text] [Related]  

  • 12. Lessons from nosocomial viral haemorrhagic fever outbreaks.
    Fisher-Hoch SP
    Br Med Bull; 2005; 73-74():123-37. PubMed ID: 16373655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ebola and Marburg viruses: the humans strike back].
    Alazard-Dany N; Ottmann Terrangle M; Volchkov V
    Med Sci (Paris); 2006 Apr; 22(4):405-10. PubMed ID: 16597410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marburg and Ebola virus infections in laboratory non-human primates: a literature review.
    Schou S; Hansen AK
    Comp Med; 2000 Apr; 50(2):108-23. PubMed ID: 10857001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of cyanovirin-N antiviral activity, by use of lentiviral vectors pseudotyped with filovirus envelope glycoproteins.
    Barrientos LG; Lasala F; Otero JR; Sanchez A; Delgado R
    J Infect Dis; 2004 Apr; 189(8):1440-3. PubMed ID: 15073681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa.
    Leroy EM; Gonzalez JP; Baize S
    Clin Microbiol Infect; 2011 Jul; 17(7):964-76. PubMed ID: 21722250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single shot against Ebola and Marburg virus.
    Baize S
    Nat Med; 2005 Jul; 11(7):720-1. PubMed ID: 16015361
    [No Abstract]   [Full Text] [Related]  

  • 18. Ebola and Marburg viruses: pathogenesis and development of countermeasures.
    Hensley LE; Jones SM; Feldmann H; Jahrling PB; Geisbert TW
    Curr Mol Med; 2005 Dec; 5(8):761-72. PubMed ID: 16375711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.
    Suschak JJ; Schmaljohn CS
    Hum Vaccin Immunother; 2019; 15(10):2359-2377. PubMed ID: 31589088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ebola and Marburg hemorrhagic fevers: neglected tropical diseases?
    MacNeil A; Rollin PE
    PLoS Negl Trop Dis; 2012 Jun; 6(6):e1546. PubMed ID: 22761967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.